Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis
Authors
Keywords
Hepatitis C virus, Salaries, Hepatitis C, United States, Egypt, Gastroenterology and hepatology, Health economics, Turkey (country)
Journal
PLOS MEDICINE
Volume 13, Issue 5, Pages e1002032
Publisher
Public Library of Science (PLoS)
Online
2016-06-01
DOI
10.1371/journal.pmed.1002032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States
- (2015) Soumitri Barua et al. ANNALS OF INTERNAL MEDICINE
- Cost-Effectiveness and Budget Impact of Hepatitis C Virus Treatment With Sofosbuvir and Ledipasvir in the United States
- (2015) Jagpreet Chhatwal et al. ANNALS OF INTERNAL MEDICINE
- A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System
- (2015) John T. Nguyen et al. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
- (2015) Ayalew Tefferi et al. MAYO CLINIC PROCEEDINGS
- Mixed HCV infection and reinfection in people who inject drugs—impact on therapy
- (2015) Evan B. Cunningham et al. Nature Reviews Gastroenterology & Hepatology
- Access to critical medicines: When are compulsory licenses effective in price negotiations?
- (2015) Shyama V. Ramani et al. SOCIAL SCIENCE & MEDICINE
- Disparity in market prices for hepatitis C virus direct-acting drugs
- (2015) Isabelle Andrieux-Meyer et al. Lancet Global Health
- Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries
- (2014) A. Hill et al. CLINICAL INFECTIOUS DISEASES
- Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response
- (2014) Kian Bichoupan et al. HEPATOLOGY
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Comparative Clinical Effectiveness and Value of Simeprevir and Sofosbuvir for Chronic Hepatitis C Virus Infection
- (2014) Daniel A. Ollendorf et al. JAMA Internal Medicine
- Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries
- (2012) Alexandra Cameron et al. EPILEPSIA
- Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America
- (2012) Veronika J Wirtz et al. HEALTH POLICY AND PLANNING
- Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine
- (2012) Jason Grebely et al. LANCET INFECTIOUS DISEASES
- Differences in external price referencing in Europe—A descriptive overview
- (2011) Christine Leopold et al. HEALTH POLICY
- Delivering affordable cancer care in high-income countries
- (2011) Richard Sullivan et al. LANCET ONCOLOGY
- Driving a decade of change: HIV/AIDS, patents and access to medicines for all
- (2011) Ellen 't Hoen et al. Journal of the International AIDS Society
- Evolving epidemiology of hepatitis C virus
- (2010) D. Lavanchy CLINICAL MICROBIOLOGY AND INFECTION
- A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries
- (2010) Brenda Waning et al. Journal of the International AIDS Society
- Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
- (2009) Paul Feuerstadt et al. HEPATOLOGY
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
- (2008) A Cameron et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started